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Durmg cardiopulmonary bypass surgery blood is extracorporeally oxygenated and circulated before returnmg to the systemic arterial circulation. 
Blood undergoing extracorporeal dilution and ctrculatton is exposed to non-physiological surfaces. which cause the activation of several regulatory 
cascades. Cells are also subJected to damaging shear stresses, Under such conditions neutrophtls can be ‘activated’ to release reactive oxygen 
intermediates such as 0; and H20,. and other cells can release proteolytic enzymes and metalloproteins. Collectively, these events can result in 
the release of micromolar quantities of redox active iron and copper. Bleomycm-detectable iron and phenanthroline-detectable copper were found 
m two out of four mock bypass experiments. However, there was no correlation between the presence of chelatable iron and copper and the 
activation of neutrophils measured as elastase 
Bypass surgery; Oxygen radical: Bleomycm-detectable non, Phenanthroline-detectable copper; Reoxygenation Injury: Anttoxidants; Elastase. 
Caeruloplasmin; Haemoglobm 
1. INTRODUCTION 2. MATERIALS AND METHODS 
There is now convincing evidence that organic and 
inorganic oxygen radicals are transiently formed when 
ischaemic heart tissue is reoxygenated (for review see 
[1.2]). In many cases oxygen radicals, and other reduc- 
tion intermediates of oxygen can be prevented, inter- 
cepted or destroyed by a variety of chemical interven- 
tions added before or during the early part of reoxyge- 
nation tieviewed in [3]). The origins of many of these 
reactive forms of oxygen remain uncertain, but much 
evidence suggests they arise multifactorially as a result 
of biochemical changes triggered during the period of 
ischaemia. Studies in several experimental animal mod- 
els of ischaemia-reoxygenation support a key role for 
chelatable forms of iron [4-61 and possibly copper [7] in 
expressing, or amplifying tissue damage caused by reac- 
tive forms of oxygen. In support of this concept animals 
placed in iron-overload show increased reoxygenation 
injury [8] and treatment with iron chelators appears to 
reduce such damage [8,9]. 
The purpose of the present study was to investigate 
whether chelatable forms of iron or copper can be re- 
leased during the extracorporeal circulation of blood, 
for cardiopulmonary bypass surgery, prior to the reox- 
ygenation of heart and lung tissue. 
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Calf thymus DNA. bleomycin sulphate. 1 .lO-phenanthrohne, bo- 
vme serum albumm and apotransferrm were from Sigma Chemical 
Co . Poole, UK. All other chemicals were of the highest grades avail- 
able from Fisons Sctentific Equipment, Loughborough, UK. Li- 
posomes were prepared from bovine brain phospholipids [lo]. Sheep 
anti-human elastase and peroxtdase-conjugated sheep anti-human a,- 
antitrypsin were from The Bmdmg Site. Birmingham, UK. 
3.1. Collertlon of blood 
A healthy male volunteer was placed supine and a tourmquet posi- 
tioned around the arm A bleb of lignocaine (1%) was introduced 
intradermally above the antecubital vem which was subsequently can- 
nulated (Abbocath 14G. Abbot Ltd.. Shgo. Ireland). Four-hundred 
ml of blood was allowed to dram mto a haematological transfer pack 
(R2074, Baxter Healthcare, Thetford. UK) containing4.000 U sodium 
heparm. The blood was added immediately to Hartmann’s solution 
(Fresemus HC Group, Basmgstoke, UK) to produce a final circutt- 
primmg volume of 1 htre (concentratton of heparin 4 U/ml). 
The control for the effects of neutrophil activatton occurring 
through the contact of blood with polyvmylchloride. a further 30 ml 
of blood was withdrawn into a syringe containing heparm m the same 
proporttons to the transfer pack and diluted to the same degree with 
Hartmann’s solution. Thts sample was kept in a static loop (see 
below), and also served as a control for blood not subjected to shear 
stresses. 
2.2. Bypass procedure 
In all experiments an extracorporeal circuit was used of the follow- 
mg composttton: 0.75 metres of 3/S mch id. polyvmylchloride tubing 
(Linx Medical Systems, Formby, UK), a bubble oxygenator mcor- 
porating a heat exchanger (William Harvey H1700, CR Bard Inc., 
MA, USA), an occlusive roller pump (Sarns Inc., Ann Arbor. MI, 
USA), a water heater-cooler (Sarns Inc., Ann Arbor, MI. USA) and 
a temperature probe connected to a contmuous display recorder 
(Dtdeco, Italy). 
The static loop control consisted of 0.5 m 3/S mch 1.d. polyvinylchlo- 
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ride tubmg connected end-to-end with a Connecta-TH 3-way tap 
connector (Viggo-Spectramed, Helsmgburg, Sweden). After the ctr- 
cuits and the static loop (control) were primed, the pump was started 
and a Aow of 3 I/mm maintained for 2 h at 37°C. while filtered an was 
passed through the oxygenator at a rate of 2 I/mm. The static loop was 
placed m a waterbath maintamed at 37°C for 2 h Blood samples were 
taken from the circuit and static loop at zero time and after 60 and 
120 mm. 
temperature. The wells were Rashed with PBST and further incubated 
for 1 h with peroxidase-conjugated sheep arm-human a,-antitrypsin 
(I :l .OOO). After further washes with PBST the substrate (0.5 mg/ml of 
o-phenylenediamme dihydrochlortde in 0.05% w/v hydrogen peroxide. 
0.1 M citric acid and 0.2 M dtsodium hydrogen phosphate) was added. 
The reaction was stopped after 20 mtn by adding 4 M sulphuric acid. 
The plates were read at an absorbance of 392 nm 
2.3. I~eu.~urefi~e~t of ch~~ut~bie won and copper 
Bleomycin-che~table iron was determmed as prevtously described 
3. RESULTS 
[II] and quantitated by measuring the amount of malondialdehyde 
(MDA) released from DNA by bleomycin-non and ascorbate. Iron 
m the btologtcal sample that can bind to bleomycm and damage DNA 
IS considered to be loosely-bound and redox active Phenanthrolme- 
chelatable copper m btological samples was measured using a stmilar 
molecular recognition assay [I21 specific for chel-‘-‘-ie redox active 
copper 
2.4. Amoxidant assays meusurrng won-bmdmg und won-o.wilsmg pro- 
tectiori 
2.4.1. Iron-bmdmg 
By adding high concentrattons of ascorbate to inhibit the ferroxi- 
dase activity of caeruloplasmm, the iron-bmdmg antioxtdant activity 
of transfefrm can be specifically measured in plasma [13]. Two detec- 
tor molecules were used to assess radical damage and resultmg anttox- 
tdant protection: (a) Phospholipid peroxidation using, 0 2 ml li- 
posomes 5 mgiml. 0.2 ml of 0.1 M sodium phosphate buffer. pH 7 4, 
IO fll of sample and 20 ~1 of ascorbate 7.5 mM in new clean plasttc 
tubes. incubated at 37°C for 20 min: (b) DNA damage usmg, 0 2 ml 
of DNA 1 mg/ml. 20 ,uI of bleomycin sulphate I.5 umts/ml. 20 ~1 of 
sample. 0.1 ml of MgCl, 50 mM. 0 1 ml of 1.0 M Trls buffer. pH 7.4. 
and 50 ~1 of ascorbate 7.5 mM. The samples were incubated in new 
clean polypropylene tubes for 30 mm at 37°C. Damage to both detec- 
tor molecules was assessed by measurmg the release of malondialde- 
hyde (MDA) and its reaction with thiobarbtturic acid (TBA) to form 
a pink chromogen absorbmg at A,,zn,,,. 
Plasma was separated from diluted blood. undergo- 
ing extracorporeal oxygenation and circulation for up 
to 120 min, and examined for the presence of chelatable 
iron and copper ions. In two out of four mock bypass 
experiments (A and B) low micromolar concentrations 
of bleomycin-chelatable iron and phenanthroline- 
chelatable-copper were detectable (Tables I and II). A 
static loop control sample which was not oxygenated or 
circulated did not contain chelatable iron or copper 
(Tables 1 and II). The plasma samples from experiments 
A and B, which showed the presence of chelatable iron 
and copper, lost antioxidant activities in assays de- 
signed to detect iron-binding and iron-o~idising protec- 
tion, and usually stimulated damage to the DNA and 
phospholipid detector molecules (Tables I and II). 
24.2. Iron-oxtdtsmg 
By sat~lrating the plasma transferrin with ferric tons, and lowering 
the ascorbate concentration, the iron-oxidlsin~ (ferroxidase) anttoxi- 
dant activity of plasma can be spectfically measured [I3]. using mixed 
phosphohpids as a detector molecule 0.2 ml of phospholiptd h- 
posomes 5 mg/ml, 0.1 ml of 0.2 M sodium phosphate buffer, pH 6.5. 
10 ,~l of plasma and 20 ,uI of ferric chloride 1 mM are mixed in new 
clean plastic tubes and the reactton started by the addition of 30~1 of 
ascorbate 0.125 mM. Tube contents were incubated at 37°C for 20 
mm. and damage to phospholiptds assessed by the development of 
TBA reactive material as described above. The results of typical exper- 
iments performed in duplicate are shown. The prectston of the assays 
has been described m detail elsewhere (see references), 
2.5. Fermcidme assay& 
Total plasma ferroxidase assays were measured kinetically as the 
oxtdation of a ferrous salt and tts loading onto apotransfcrrln to form 
the pmk dtferric complex [l4]. Ferrowtdase actrvtttes not due to caeru- 
loplasmin (ferroxtdase I) were measured by performmg the assays m 
the presence of azide. 
For measurement of ferroxidase activities suitable 
plasma was only available from experiment A (showing 
chelatable copper) and experiment D (not showing che- 
latable copper). Both samples showed a tendency for 
ferroxidase activities to fall slightly during bypass (A 
fell from 0.187 to 0.165, and D from 0.200 to 0.186 
IU/ml) although insufficient data were available to as- 
sess the significance. 
Plasma levels of elastase-~,-antitrypsin complex in- 
creased sig~iifi~antly (P = 0.05) in samples A. C and D 
during the 120 min extracorporeal circulation of blood 
when compared with the static loop controls (Fig. If, 
confirming neutrophil activation was occurring. How- 
ever, in sample ‘B’ elastase levels did not appear to 
increase (Table II). 
4. DISCUSSION 
During cardiopulmonary bypass surgery, blood is re- 
moved from the systemic venous circulation and 
pumped through an extracorporeal oxygenator before 
returning to the systemic arterial circulation. Blood un- 
dergoing extracorporeal oxygenation is known to en- 
counter abnormal stimuli, such as massive exposure to 
non-physiological surfaces and shear stresses-[1 51. Ex- 
posure of blood to any foreign surface activates clot- 
ting, fibrinolytic, complement and kallikrein/kinin cas- 
cades, and the shear stresses generated by blood pumps, 
suction systems and cavitation at the end of arterial 
cannulae lead to red blood cell lysis and the release of 
haemoglobin. A combination of such events can facili- 
tate the release of proteolytic enzymes and the forma- 
tion of reactive forms of oxygen, and some or all of 
2.6. Qrculutmg neutrophil elastase 
In plasma, free neutrophtl elastase IS tmmedtately bound to a,- 
antttrypsin. The ctrculating levels of this complex were measured by 
an ELISA techmque. 96-well plates (Greiner, Germany) were coated 
with 100 ,uI of sheep anti-human elastase (15 &ml m a 0.1 M sodium 
carbonate-bicarbonate buffer, pH 9.6. for 24 h at room temperature, 
and then washed with 0 1 M sodmm phosphate in 0.15 M sodium 
chloride contammg 0.1% v/v Tween 20 (PBST). and blocked with 1% 
w/v bovine serum albumin. Standards and samples were diluted 1,100 
to 1500 v&h PBST, added to the wells and incubated for 2 h at room 
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Table I 
Release of bleomycin-detectable iron from blood during bypass pumping 
August 1993 
Plasma 
bleomycin-detectable iron 
@mol/l) 
Plasma 
iron-bmding-dependent 
antioxidant activity (oxo-iron species) 
%Inhib (I); %Stim (S) 
Plasma 
iron-binding-dependent 
antioxidant activity (lipid radicals) 
%Inhib (I); %Stim (S) 
Control blood m static loop 
0 min 
60 min 
120 min 
Bypuss circulated blood 
Sample A 0 
60 
120 
Sample B 0 
60 
120 
Sample C 0 
60 
120 
Sample D 0 
60 
120 
0 
0 
0 
0 
0.39 
1.37 
0 
0 
0.21 
0 
0 
0 
0 
0 
0 
16% I 46% I 
17% I 43% I 
12% 1 32% I 
10% I 27% I 
10% s 8% I 
33% s 56% S 
21% I 30% I 
9% I 6% S 
4% s 33% s 
17% I 73% I 
10% I 69% I 
6% I 34% I 
10% I 
11% I 
8% I 
73% I 
59% I 
57% 1 
these may contribute to several of the recognised ad- 
verse effects of bypass surgery, such as those occurring 
during the proposed widespread intravascular inflam- 
matory response [16]. During bypass it is known that 
complement is activated [17], as was confirmed in our 
study (data not shown). In addition, extracorporeal ox- 
Table II 
Release of phenanthroline-detectable copper from blood during bypass pumping 
Plasma 
phenanthroline-detectable 
copper @mol/l) 
Plasma iron-oxtdising 
dependent antioxidant acttvity 
(lipid radicals) 
%Inhib (I); %Stim (S) 
Plasma elastase 
(ng/ml) 
Control blood m slatic loop 
0 min 
60 min 
120 min 
0 18% I 155 
0 14% I 160 
0 6% I 180 
B~puss clrculuied blood 
Sample A 0 
60 
120 
0 10% I 155 
0.20 1% I 360 
0.20 13% s 600 
Sample B 0 0 2% I 125 
60 0.10 3% s 125 
120 0.20 6% S 130 
Sample C 0 0 12% I 140 
60 0 11% I 390 
120 0 26% I 740 
Sample D 0 0 39% I 135 
60 0 21% I 285 
120 0 31% I 510 
105 
Volume 328, number 1.2 FEBS LETTERS August 1993 
600 * = static 
400 
300 
1 
0 30 60 90 120 
time (minutes) 
Fig. 1. Plasma elastase values (ng/ml) are shown at time pomts from 
‘0’ to 120 mm m a typical bypass where blood was circulated extracor- 
poreally (v) or left in a static loop (A) 
ygenation and circulation in most cases leads to a signif- 
icant activation of neutrophils leading to increased lev- 
els of plasma elastase. 
Human plasma from normal healthy individuals does 
not contain chelatable forms of iron or copper [11,12]. 
Iron is tightly sequestered to the iron-transport protein 
transferrin. occupying only one third of its iron-binding 
potential, whereas copper exists predominantly as part 
of the structure of the plasma protein caeruloplasmin. 
The iron-binding capacity of transferrin gives it a con- 
siderable antioxidant potential to inhibit oxygen radical 
formation driven by iron salts [13]. This antioxidant 
activity is lost when the transferrin becomes fully iron 
saturated, as occurs in conditions of iron-overload. The 
origin of the chelatable iron present in two of our mock 
bypass experiments is not entirely clear, but may in- 
volve haemoglobin released from red blood cells by 
shear stresses. When hydrogen peroxide is released 
from activated neutrophils, in sufficient quantities it has 
the potential to facilitate the release of chelatable iron 
from haemoglobin [ 181. 
Caeruloplasmin. the major copper-containing pro- 
tein of human plasma, can catalyse the oxidation of 
ferrous ions to the ferric state (ferroxidase I activity) 
[14]. This activity, however, can be rapidly lost when 
caeruloplasmin is degraded. Proteolytic degradation of 
caeruloplasmin begins as soon as blood is withdrawn 
from the body, and accelerates when plasma is stored 
or mishandled [ 191, causing release of chelatable copper 
fragments which cause lipoprotein oxidation in vitro 
[ 191. The resulting oxidised lipid-proteinxopper com- 
plex has an azide non-inhibitable ferroxidase(I1) activity 
[30]. Normal plasma contains around 17.0 ymolll of 
copper and almost all of this is associated with caer- 
uloplasmin. Red blood cells, on the other hand, contain 
some 10.0 pmollkg of copper which is mostly associated 
with the enzyme superoxide dismutase. The origin of the 
chelatable copper detected in two of our bypass experi- 
ments is, at present, unclear. 
Extracorporeal oxygenation and circulation of blood 
in Harmann’s solution is here shown to lead to the 
release of chelatable iron and copper. Both iron and 
copper ions can amplify oxidative damage when tissue 
is reoxygenated. Attempts to limit the involvement of 
such metal complexes in oxidative damage. by interven- 
ing with antioxidants and metal chelators, is at present 
being considered. 
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